ホーム › 心不全 › ミネソタ州 › Minneapolis
Minneapolis、MNにおける心不全の臨床試験
Minneapolisとその周辺地域（約30マイル以内）の拠点で、心不全に関する21件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
ELEVATE-HFpEF Clinical Study
被験者募集中
- M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
被験者募集中第3相
- Minneapolis VA Health Care System, Minneapolis
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
被験者募集中第3相
- Minneapolis VA Health Care System, Minneapolis
Alleviant ALLAY-HFrEF Study
被験者募集中
- Minneapolis Heart Institute Foundation, Minneapolis
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
被験者募集中第3相
- University of Minnesota, Minneapolis
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
被験者募集中第3相
- Research Site, Minneapolis
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
被験者募集中第3相
- Minneapolis, MN Investigative Site CON-10035, Minneapolis
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
被験者募集中第3相
- Minneapolis, MN Investigative Site 10091, Minneapolis
- Minneapolis, MN Investigative Site 10035, Minneapolis
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
被験者募集中
- Abbott Northwestern Hospital, Minneapolis
- University of Minnesota, Minneapolis
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
被験者募集中観察研究
- Minneapolis, Minneapolis
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
被験者募集中観察研究
- Minneapolis Heart Institute Foundation, Minneapolis
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
被験者募集中第3相
- Tenax Investigational Site, Minneapolis
Alleviant ALLAY-HF Study
被験者募集中
- Minneapolis Heart Institute Foundation, Minneapolis
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
被験者募集中
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Assessment of CCM in HF With Higher Ejection Fraction
被験者募集中
- Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
被験者募集中第3相
- Minneapolis, MN Investigative Site FIN-10035, Minneapolis
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
被験者募集中
- University of Minnesota, Minneapolis
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
被験者募集中
- Minneapolis Heart Institute, Minneapolis
CCM OPEN HF Registry
被験者募集中観察研究
- Minneapolis Heart Institute Research Foundation, Minneapolis
Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance
被験者募集中観察研究
- Minneapolis Heart Institute Foundation, Minneapolis
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
被験者募集中観察研究
- Minneapolis Heart Institute Foundation/ Allina Health, Minneapolis
他の都市における心不全の試験
- New York City, NY51件の研究
- Boston, MA44件の研究
- Dallas, TX42件の研究
- Houston, TX36件の研究
- Cleveland, OH33件の研究
- Chicago, IL31件の研究
- Philadelphia, PA31件の研究
- San Francisco, CA29件の研究
- St. Louis, MO26件の研究
- Durham, NC26件の研究
- Kansas City, MO25件の研究
- Atlanta, GA25件の研究
Minneapolisにおける他の研究
- 乳がん27件の研究
- 非小細胞肺癌26件の研究
- 卵巣がん24件の研究
- 前立腺がん23件の研究
- がん（全種類）22件の研究
- 肺がん20件の研究
- 急性骨髄性白血病20件の研究
- 大腸癌19件の研究
- 子宮内膜がん18件の研究
- パーキンソン病17件の研究
- 心血管疾患15件の研究
- 冠動脈疾患13件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。